Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

valdecoxib

A sulfonamide derivative and non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic activities. Valdecoxib selectively binds to and inhibits cyclooxygenase (COX)-2, thereby preventing the conversion of arachidonic acid into prostaglandins, which are involved in the regulation of pain, inflammation, and fever. This NSAID does not inhibit COX-1 at therapeutic concentrations and therefore does not interfere with blood coagulation.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
US brand name:Bextra
Code name:SC 65872
Chemical structure:4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search